Endocrine

, Volume 41, Issue 2, pp 176–182 | Cite as

Vaspin in obesity and diabetes: pathophysiological and clinical significance

Review

Abstract

Vaspin (visceral adipose tissue-derived serpin; serpinA12) was originally identified as an adipokine, which is predominantly secreted from visceral adipose tissue in Otsuka Long-Evans Tokushima fatty (OLETF), an animal model of obesity and type 2 diabetes. Consistent with that higher vaspin serum concentrations and increased vaspin mRNA expression in human adipose tissue were found to be associated with obesity, insulin resistance, and type 2 diabetes in humans. However, the mechanisms how vaspin secretion may be linked to deterioration of glucose metabolism and insulin sensitivity are not entirely understood. Vaspin serum concentrations show a food intake-related diurnal variation. Vaspin is also expressed in the skin, hypothalamus, pancreatic islets, and stomach. Administration of vaspin to obese mice improves glucose tolerance, insulin sensitivity, and reduces food intake. Until now molecular target(s) of vaspin and its mode of action are unknown. Thus, identification of the proteases, which are inhibited by vaspin may lead to the development of novel strategies in the treatment of obesity, diabetes and insulin resistance. This review discusses the clinical relevance of vaspin in the pathophysiology of obesity and type 2 diabetes.

Keywords

Vaspin Adipokines Obesity Type 2 diabetes Visceral obesity 

References

  1. 1.
    E.E. Kershaw, J.S. Flier, Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab. 89, 2548–2556 (2004)PubMedCrossRefGoogle Scholar
  2. 2.
    N.E. Gulcelik, A. Usman, A. Gürlek, Role of adipocytokines in predicting the development of diabetes and its late complications. Endocrine 36, 397–403 (2009)PubMedCrossRefGoogle Scholar
  3. 3.
    M. Blüher, Adipose tissue dysfunction in obesity. Exp. Clin. Endocrinol. Diabetes 117, 241–250 (2009)PubMedCrossRefGoogle Scholar
  4. 4.
    H.E. Bays, “Sick fat,” metabolic disease, and atherosclerosis. Am. J. Med. 122, S26–S37 (2009)PubMedCrossRefGoogle Scholar
  5. 5.
    S. Kralisch, M. Blüher, R. Paschke, M. Stumvoll, M. Fasshauer, Adipokines and adipocyte targets in the future management of obesity and the metabolic syndrome. Mini Rev. Med. Chem. 7, 39–45 (2007)PubMedCrossRefGoogle Scholar
  6. 6.
    L.F. Van Gaal, I.L. Mertens, C.E. DeBlock, Mechanisms linking obesity with cardiovascular disease. Nature 444, 875–880 (2006)PubMedCrossRefGoogle Scholar
  7. 7.
    M. Blüher, The inflammatory process of adipose tissue. Pediatr. Endocrinol. Rev. 6, 24–31 (2008)PubMedGoogle Scholar
  8. 8.
    G.S. Hotamisligil, Mechanisms of TNF-alpha-induced insulin resistance. Exp. Clin. Endocrinol. Diabetes 107, 119–125 (1999)PubMedCrossRefGoogle Scholar
  9. 9.
    A. Guilherme, J.V. Virbasius, V. Puri, M.P. Czech, Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Natl. Rev. Mol. Cell. Biol. 9, 367–377 (2008)CrossRefGoogle Scholar
  10. 10.
    Y. Zhang, R. Proenca, M. Maffei, M. Barone, L. Leopold, J.M. Friedman, Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425–432 (1994)PubMedCrossRefGoogle Scholar
  11. 11.
    R.S. Ahima, J.S. Flier, Leptin. Annu. Rev. Physiol. 62, 413–437 (2000)PubMedCrossRefGoogle Scholar
  12. 12.
    H. Chen, O. Charlat, L.A. Tartaglia, E.A. Woolf, X. Weng, S.J. Ellis, N.D. Lakey, J. Culpepper, K.J. Moore, R.E. Breitbart, G.M. Duyk, R.I. Tepper, J.P. Morgenstern, Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 84, 491–495 (1996)PubMedCrossRefGoogle Scholar
  13. 13.
    K. Brochu-Gaudreau, C. Rehfeldt, R. Blouin, V. Bordignon, B.D. Murphy, M.F. Palin, Adiponectin action from head to toe. Endocrine 37, 11–32 (2010)PubMedCrossRefGoogle Scholar
  14. 14.
    M.E. Trujillo, P.E. Scherer, Adiponectin—journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J. Intern. Med. 257, 167–175 (2005)PubMedCrossRefGoogle Scholar
  15. 15.
    I. Castan-Laurell, C. Dray, C. Attané, T. Duparc, C. Knauf, P. Valet, Apelin, diabetes, and obesity. Endocrine 40, 1–9 (2011)PubMedCrossRefGoogle Scholar
  16. 16.
    K. Hida, J. Wada, J. Eguchi, H. Zhang, M. Baba, A. Seida, I. Hashimoto, T. Okada, A. Yasuhara, A. Nakatsuka, K. Shikata, S. Hourai, J. Futami, E. Watanabe, Y. Matsuki, R. Hiramatsu, S. Akagi, H. Makino, Y.S. Kanwar, Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proc. Natl. Acad. Sci. USA 102, 10610–10615 (2005)PubMedCrossRefGoogle Scholar
  17. 17.
    J. Wada, Vaspin and insulin resistance. Rinsho Byori 56, 705–711 (2008)PubMedGoogle Scholar
  18. 18.
    N. Klöting, P. Kovacs, M. Kern, J.T. Heiker, M. Fasshauer, M.R. Schön, M. Stumvoll, A.G. Beck-Sickinger, M. Blüher, Central vaspin administration acutely reduces food intake and has sustained blood glucose-lowering effects. Diabetologia 54, 1819–1823 (2011)PubMedCrossRefGoogle Scholar
  19. 19.
    P.G. Gettins, Serpin structure, mechanism, and function. Chem. Rev. 102, 4751–4804 (2002)PubMedCrossRefGoogle Scholar
  20. 20.
    R.H. Law, Q. Zhang, S. MacGowan, A.M. Buckle, G.A. Silverman, W. Wong, C.J. Rosado, C.G. Langendorf, R.N. Pike, P.I. Bird, J.C. Whisstock, An overview of the serpin superfamily. Genome Biol. 7, 216 (2006)PubMedCrossRefGoogle Scholar
  21. 21.
    G.A. Silverman, P.I. Bird, R.W. Carrell, F.C. Church, P.B. Coughlin, P.G. Gettins, J.A. Irving, D.A. Lomas, C.J. Luke, R.W. Moyer, P.A. Pemberton, E. Remold-O’Donnell, G.S. Salvesen, J. Travis, J.C. Whisstock, The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J. Biol. Chem. 276, 33293–33296 (2001)PubMedCrossRefGoogle Scholar
  22. 22.
    K. Kempf, B. Rose, T. Illig, W. Rathmann, K. Strassburger, B. Thorand, C. Meisinger, H.E. Wichmann, C. Herder, C. Vollmert, Vaspin (SERPINA12) genotypes and risk of type 2 diabetes: results from the MONICA/KORA studies. Exp. Clin. Endocrinol. Diabetes 118, 184–189 (2010)PubMedCrossRefGoogle Scholar
  23. 23.
    N. Klöting, J. Berndt, S. Kralisch, P. Kovacs, M. Fasshauer, M.R. Schön, M. Stumvoll, M. Blüher, Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes. Biochem. Biophys. Res. Commun. 339, 430–436 (2006)PubMedCrossRefGoogle Scholar
  24. 24.
    A. Körner, M. Neef, D. Friebe, S. Erbs, J. Kratzsch, K. Dittrich, S. Blüher, T.M. Kapellen, P. Kovacs, M. Stumvoll, M. Blüher, W. Kiess, Vaspin is related to gender, puberty and deteriorating insulin sensitivity in children. Int. J. Obes. (Lond.) 35, 578–586 (2011)CrossRefGoogle Scholar
  25. 25.
    J.N. Fain, B. Buehrer, S.W. Bahouth, D.S. Tichansky, A.K. Madan, Comparison of messenger RNA distribution for 60 proteins in fat cells vs the nonfat cells of human omental adipose tissue. Metabolism 57, 1005–1015 (2008)PubMedCrossRefGoogle Scholar
  26. 26.
    U. Meyer-Hoffert, Reddish, scaly, and itchy: how proteases and their inhibitors contribute to inflammatory skin diseases. Arch. Immunol. Ther. Exp. 57, 345–354 (2009)CrossRefGoogle Scholar
  27. 27.
    B.S. Youn, N. Klöting, J. Kratzsch, N. Lee, J.W. Park, E.S. Song, K. Ruschke, A. Oberbach, M. Fasshauer, M. Stumvoll, M. Blüher, Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes 57, 372–377 (2008)PubMedCrossRefGoogle Scholar
  28. 28.
    C. von Loeffelholz, M. Möhlig, A.M. Arafat, F. Isken, J. Spranger, K. Mai, H.S. Randeva, A.F. Pfeiffer, M.O. Weickert, Circulating vaspin is unrelated to insulin sensitivity in a cohort of nondiabetic humans. Eur. J. Endocrinol. 162, 507–513 (2010)CrossRefGoogle Scholar
  29. 29.
    G. Aust, O. Richter, S. Rohm, C. Kerner, J. Hauss, N. Klöting, K. Ruschke, B.S. Youn, M. Blüher, Vaspin serum concentrations in patients with carotid stenosis. Atherosclerosis 204, 262–266 (2009)PubMedCrossRefGoogle Scholar
  30. 30.
    A. Handisurya, M. Riedl, G. Vila, C. Maier, M. Clodi, T. Prikoszovich, B. Ludvik, G. Prager, A. Luger, A. Kautzky-Willer, Serum vaspin concentrations in relation to insulin sensitivity following RYGB-induced weight loss. Obes. Surg. 20, 198–203 (2010)PubMedCrossRefGoogle Scholar
  31. 31.
    B.L. Tan, D. Heutling, J. Chen, S. Farhatullah, R. Adya, S.D. Keay, C.R. Kennedy, H. Lehnert, H.S. Randeva, Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance. Diabetes 57, 1501–1507 (2008)PubMedCrossRefGoogle Scholar
  32. 32.
    N.E. Gulcelik, J. Karakaya, A. Gedik, A. Usman, A. Gurlek, Serum vaspin levels in type 2 diabetic women in relation to microvascular complications. Eur. J. Endocrinol. 160, 65–70 (2009)PubMedCrossRefGoogle Scholar
  33. 33.
    J. Seeger, M. Ziegelmeier, A. Bachmann, U. Lössner, J. Kratzsch, M. Blüher, M. Stumvoll, M. Fasshauer, Serum levels of the adipokine vaspin in relation to metabolic and renal parameters. J. Clin. Endocrinol. Metab. 93, 247–251 (2008)PubMedCrossRefGoogle Scholar
  34. 34.
    N.P. Kadoglou, A. Kapelouzou, H. Tsanikidis, I. Vitta, C.D. Liapis, N. Sailer, Effects of rosiglitazone/metformin fixed-dose combination therapy and metformin monotherapy on serum vaspin, adiponectin and IL-6 levels in drug-naïve patients with type 2 diabetes. Exp. Clin. Endocrinol. Diabetes 119, 63–68 (2011)PubMedCrossRefGoogle Scholar
  35. 35.
    S. Akbarzadeh, I. Nabipour, S.M. Jafari, A. Movahed, N. Motamed, M. Assadi, N. Hajian, Serum visfatin and vaspin levels in normoglycemic first-degree relatives of Iranian patients with type 2 diabetes mellitus. Diabetes Res. Clin. Pract. (2011). doi:10.1016/j.diabres.2011.10.004
  36. 36.
    N. Cinar, N.E. Gülçelik, K. Aydín, S. Akín, A. Usman, A. Gürlek, Serum vaspin levels in hypothyroid patients. Eur. J. Endocrinol. 165, 563–569 (2011)PubMedCrossRefGoogle Scholar
  37. 37.
    J.A. Lee, H.S. Park, Y.S. Song, Y.J. Jang, J.H. Kim, Y.J. Lee, Y.S. Heo, Relationship between vaspin gene expression and abdominal fat distribution of Korean women. Endocr. J. 8, 639–646 (2011)CrossRefGoogle Scholar
  38. 38.
    N. Klöting, M. Fasshauer, A. Dietrich, P. Kovacs, M.R. Schön, M. Kern, M. Stumvoll, M. Blüher, Insulin-sensitive obesity. Am. J. Physiol. Endocrinol. Metab. 299, E506–E515 (2010)PubMedCrossRefGoogle Scholar
  39. 39.
    H.L. Li, W.H. Peng, S.T. Cui, H. Lei, Y.D. Wei, W.M. Li, Y.W. Xu, Vaspin plasma concentrations and mRNA expressions in patients with stable and unstable angina pectoris. Clin. Chem. Lab. Med. 49, 1547–1554 (2011)PubMedCrossRefGoogle Scholar
  40. 40.
    N.P. Kadoglou, A. Gkontopoulos, A. Kapelouzou, G. Fotiadis, E.K. Theofilogiannakos, G. Kottas, S. Lampropoulos, Serum levels of vaspin and visfatin in patients with coronary artery disease—Kozani study. Clin. Chim. Acta 412, 48–52 (2011)PubMedCrossRefGoogle Scholar
  41. 41.
    Y. Yilmaz, R. Kurt, A. Gurdal, Y.O. Alahdab, O. Yonal, E. Senates, N. Polat, F. Eren, N. Imeryuz, H. Oflaz, Circulating vaspin levels and epicardial adipose tissue thickness are associated with impaired coronary flow reserve in patients with nonalcoholic fatty liver disease. Atherosclerosis 217, 125–129 (2011)PubMedCrossRefGoogle Scholar
  42. 42.
    S.G. Spiroglou, C.G. Kostopoulos, J.N. Varakis, H.H. Papadaki, Adipokines in periaortic and epicardial adipose tissue: differential expression and relation to atherosclerosis. J. Atheroscler. Thromb. 17, 115–130 (2010)PubMedCrossRefGoogle Scholar
  43. 43.
    C.H. Jung, W.J. Lee, J.Y. Hwang, S.M. Seol, Y.M. Kim, Y.L. Lee, J.Y. Park, Vaspin protects vascular endothelial cells against free fatty acid-induced apoptosis through a phosphatidylinositol 3-kinase/Akt pathway. Biochem. Biophys. Res. Commun. 413, 264–269 (2011)PubMedCrossRefGoogle Scholar
  44. 44.
    N.P. Kadoglou, I.S. Vrabas, A. Kapelouzou, S. Lampropoulos, N. Sailer, A. Kostakis, C.D. Liapis, Impact of atorvastatin on serum vaspin levels in hypercholesterolemic patients with moderate cardiovascular risk. Regul. Pept. 170, 57–61 (2011)PubMedCrossRefGoogle Scholar
  45. 45.
    J.K. Cho, T.K. Han, H.S. Kang, Combined effects of body mass index and cardio/respiratory fitness on serum vaspin concentrations in Korean young men. Eur. J. Appl. Physiol. 108, 347–353 (2010)PubMedCrossRefGoogle Scholar
  46. 46.
    S.M. Kim, G.J. Cho, M. Yannakoulia, T.G. Hwang, I.H. Kim, E.K. Park, C.S. Mantzoros, Lifestyle modification increases circulating adiponectin concentrations but does not change vaspin concentrations. Metabolism 60, 1294–1299 (2011)PubMedCrossRefGoogle Scholar
  47. 47.
    A. Oberbach, K. Kirsch, S. Lehmann, N. Schlichting, M. Fasshauer, K. Zarse, M. Stumvoll, M. Ristow, M. Blüher, P. Kovacs, Serum vaspin concentrations are decreased after exercise-induced oxidative stress. Obes. Facts 3, 328–331 (2010)PubMedCrossRefGoogle Scholar
  48. 48.
    M. Ristow, K. Zarse, A. Oberbach, N. Klöting, M. Birringer, M. Kiehntopf, M. Stumvoll, C.R. Kahn, M. Blüher, Antioxidants prevent health-promoting effects of physical exercise in humans. Proc. Natl. Acad. Sci. USA 106, 8665–8670 (2009)PubMedCrossRefGoogle Scholar
  49. 49.
    A. Tönjes, M. Fasshauer, J. Kratzsch, M. Stumvoll, M. Blüher, Adipokine pattern in subjects with impaired fasting glucose and impaired glucose tolerance in comparison to normal glucose tolerance and diabetes. PLoS ONE 5, e13911 (2010)PubMedCrossRefGoogle Scholar
  50. 50.
    E. Jeong, B.S. Youn, D.W. Kim, E.H. Kim, J.W. Park, C. Namkoong, J.Y. Jeong, S.Y. Yoon, J.Y. Park, K.U. Lee, M.S. Kim, Circadian rhythm of serum vaspin in healthy male volunteers: relation to meals. J. Clin. Endocrinol. Metab. 95, 1869–1875 (2010)PubMedCrossRefGoogle Scholar
  51. 51.
    L. Brunetti, C. Di Nisio, L. Recinella, A. Chiavaroli, S. Leone, C. Ferrante, G. Orlando, M. Vacca, Effects of vaspin, chemerin and omentin-1 on feeding behavior and hypothalamic peptide gene expression in the rat. Peptides 32, 1866–1871 (2011)PubMedCrossRefGoogle Scholar
  52. 52.
    L.J. Aronne, T. Wadden, K.K. Isoldi, K.A. Woodworth, When prevention fails: obesity treatment strategies. Am. J. Med. 122, S24–S32 (2009)PubMedCrossRefGoogle Scholar
  53. 53.
    I. Shai, D. Schwarzfuchs, Y. Henkin, D.R. Shahar, S. Witkow, I. Greenberg, R. Golan, D. Fraser, A. Bolotin, H. Vardi, O. Tangi-Rozental, R. Zuk-Ramot, B. Sarusi, D. Brickner, Z. Schwartz, E. Sheiner, R. Marko, E. Katorza, J. Thiery, G.M. Fiedler, M. Blüher, M. Stumvoll, M.J. Stampfer, Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N. Engl. J. Med. 359, 229–241 (2008)PubMedCrossRefGoogle Scholar
  54. 54.
    M. Blüher, A. Rudich, N. Klöting, R. Golan, Y. Henkin, E. Rubin, D. Schwarzfuchs, Y. Gepner, M. J. Stampfer, M. Fiedler, J. Thiery, M. Stumvoll, I. Shai, Two patterns of adipokine and other biomarker dynamics in a long term weight loss intervention. Diabetes Care (2011, in press)Google Scholar
  55. 55.
    E. Koiou, K. Tziomalos, K. Dinas, I. Katsikis, E. Kalaitzakis, D. Delkos, E.A. Kandaraki, D. Panidis, The effect of weight loss and treatment with metformin on serum vaspin levels in women with polycystic ovary syndrome. Endocr. J. 58, 237–246 (2011)PubMedCrossRefGoogle Scholar
  56. 56.
    G.A. Martos-Moreno, J. Kratzsch, A. Körner, V. Barrios, F. Hawkins, W. Kiess, J. Argente, Serum visfatin and vaspin levels in prepubertal children: effect of obesity and weight loss after behavior modifications on their secretion and relationship with glucose metabolism. Int. J. Obes. (Lond.) 35, 1355–1362 (2011)CrossRefGoogle Scholar
  57. 57.
    H.M. Chang, H.J. Lee, H.S. Park, J.H. Kang, K.S. Kim, Y.S. Song, Y.J. Jang, Effects of weight reduction on serum vaspin concentrations in obese subjects: modification by insulin resistance. Obesity 18, 2105–2110 (2010)PubMedCrossRefGoogle Scholar
  58. 58.
    E.S. Kang, F. Magkos, E. Sienkiewicz, C.S. Mantzoros, Circulating vaspin and visfatin are not affected by acute or chronic energy deficiency or leptin administration in humans. Eur. J. Endocrinol. 164, 911–917 (2011)PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Department of MedicineUniversity of LeipzigLeipzigGermany

Personalised recommendations